NPCENeuroPace, Inc.

$482M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+19.2% YoY

Gross Profit

$16M75.4% margin

Operating Income

-$4M-17.0% margin

Net Income

-$5M-24.5% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$95M

Total Liabilities

$87M

Stockholders' Equity

$8M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$18M	+19.2%
Gross Profit	$16M	$14M	+19.5%
Operating Income	-$4M	-$5M	+27.7%
Net Income	-$5M	-$6M	+15.3%

NPCE Q4 2024 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena